Author Correction: Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis.

Wyllie, Susan; Thomas, Michael; Patterson, Stephen; Crouch, Sabrinia; De Rycker, Manu; Lowe, Rhiannon; Gresham, Stephanie; Urbaniak, Michael D; Otto, Thomas D; Stojanovski, Laste; Simeons, Frederick R C; Manthri, Sujatha; MacLean, Lorna M; Zuccotto, Fabio; Homeyer, Nadine; Pflaumer, Hannah; Boesche, Markus; Sastry, Lalitha; Connolly, Paul; Albrecht, Sebastian; Berriman, Matt; Drewes, Gerard; Gray, David W; Ghidelli-Disse, Sonja; Dixon, Susan; Fiandor, Jose M; Wyatt, Paul G; Ferguson, Michael A J; Fairlamb, Alan H; Miles, Timothy J; Read, Kevin D; Gilbert, Ian H

Wyllie, Susan; Thomas, Michael; Patterson, Stephen; Crouch, Sabrinia; De Rycker, Manu; Lowe, Rhiannon; Gresham, Stephanie; Urbaniak, Michael D; Otto, Thomas D; Stojanovski, Laste; Simeons, Frederick R C; Manthri, Sujatha; MacLean, Lorna M; Zuccotto, Fabio; Homeyer, Nadine; Pflaumer, Hannah; Boesche, Markus; Sastry, Lalitha; Connolly, Paul; Albrecht, Sebastian; Berriman, Matt; Drewes, Gerard; Gray, David W; Ghidelli-Disse, Sonja; Dixon, Susan; Fiandor, Jose M; Wyatt, Paul G; Ferguson, Michael A J; Fairlamb, Alan H; Miles, Timothy J; Read, Kevin D; Gilbert, Ian H.

Afiliación

Wyllie S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Thomas M; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Patterson S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Crouch S; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain.
De Rycker M; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Lowe R; David Jack Centre for R&D, GlaxoSmithKline, Ware, UK.
Gresham S; David Jack Centre for R&D, GlaxoSmithKline, Ware, UK.
Urbaniak MD; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Otto TD; Division of Biomedical and Life Sciences, Faculty of Health and Medicine, Lancaster University, Lancaster, UK.
Stojanovski L; Wellcome Sanger Institute, Cambridge, UK.
Simeons FRC; Centre of Immunobiology, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Manthri S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
MacLean LM; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Zuccotto F; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Homeyer N; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Pflaumer H; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Boesche M; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Sastry L; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany.
Connolly P; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany.
Albrecht S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Berriman M; GlaxoSmithKline, New Frontiers Science Park, Harlow, UK.
Drewes G; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Gray DW; Wellcome Sanger Institute, Cambridge, UK.
Ghidelli-Disse S; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany.
Dixon S; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Fiandor JM; Cellzome GmbH, A GlaxoSmithKline Company, Heidelberg, Germany.
Wyatt PG; Global Health R&D, GlaxoSmithKline, Stockley Park West, Uxbridge, UK.
Ferguson MAJ; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain.
Fairlamb AH; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Miles TJ; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Read KD; Drug Discovery Unit, Wellcome Centre for Anti-Infectives Research, Division of Biological Chemistry and Drug Discovery, School of Life Sciences, University of Dundee, Dundee, UK.
Gilbert IH; Global Health R&D, GlaxoSmithKline, Tres Cantos, Spain. tim.j.miles@gsk.com.

Nature ; 619(7970): E48, 2023 Jul.

Article en En | MEDLINE | ID: mdl-37402863

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Nature Año: 2023 Tipo del documento: Article